GlassScriptPhysician profile
Leslie R Delaney
NPI 1124110309
$6,953.09
in general payments reported to CMS, 2019-2025
34 companies · $444 in 2025
The $444 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,898 · 2020: $431 · 2021: $1,059 · 2022: $828 · 2023: $435 · 2024: $858 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Travel and Lodging: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.00 |
| Travel and Lodging | $157.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,139.54 | 2019-2020 | |
| Vertos Medical, INC. | $1,036.77 | 2020-2024 | Mild Device Kit |
| Boston Scientific Corporation | $575.19 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $571.15 | 2019-2025 | Belbuca |
| Medtronic, INC. | $270.09 | 2021-2024 | Kyphon Express II Kyphopak Tray |
| Fidia Pharma USA INC. | $207.64 | 2019-2024 | Hymovis, Triluron |
| Spr Therapeutics, INC | $201.22 | 2025 | Sprint Pns System |
| Forte Bio-Pharma LLC | $160.01 | 2021-2024 | Prolate, Nalocet |
| Endo Pharmaceuticals INC. | $155.86 | 2019-2020 | |
| Nevro Corp. | $143.35 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $133.81 | 2019-2022 | |
| Pfizer INC. | $125.79 | 2019-2020 | |
| Radius Health, INC. | $121.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.05 | 2021-2024 | Relistor |
| Grt US Holding, INC. | $105.76 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $93.21 | 2024-2025 | Evoke |
| Biodelivery Sciences International, INC. | $83.48 | 2019-2020 | |
| Redhill Biopharma INC. | $68.37 | 2021-2023 | |
| Almatica Pharma LLC | $62.33 | 2021 | |
| Medtronic USA, INC. | $61.09 | 2019-2020 | |
| Averitas Pharma INC. | $59.75 | 2023-2025 | Qutenza |
| Kaleo, INC. | $53.94 | 2019 | |
| Neurometrix INC | $51.05 | 2023 | |
| Zyla Life Sciences, INC. | $50.14 | 2020 | |
| Relievant Medsystems, INC. | $49.73 | 2023 | Intracept |
| Globus Medical, INC. | $42.85 | 2025 | Senza |
| Hikma Pharmaceuticals USA | $38.26 | 2021 | |
| Si-Bone, INC. | $37.67 | 2022-2024 | |
| Abbvie INC. | $32.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $30.35 | 2019-2020 | |
| Avanos Medical | $28.15 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.80 | 2022 | |
| Ethicon US, LLC | $16.81 | 2022 | |
| Ibsa Pharma INC. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.